AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18555744 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (control)
Number of subjects: 25
Study 18001585 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.23% fluoride foam
Number of subjects: 392
Study 18001585 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 392
Study 15533485 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 2 g three times daily on the day of and the first day after the operation
Number of subjects: 136
Study 15533485 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 136
Study 15533485 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 136
Study 11403540 — intervention group
Group type: EXPERIMENTAL
Intervention: H2-receptor antagonists (cimetidine or ranitidine) or proton pump inhibitors
Number of subjects: 0
Study 11403540 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipase (at least 90,000 USP units) taken with acid suppression agents
Number of subjects: 0
Study 9740281 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline (500 mg qid in adults and 12.5 mg/kg qid in children) for 3 days
Number of subjects: 25
Study 9740281 — intervention group
Group type: COMPARATOR
Intervention: Norfloxacin (400 mg bid in adults and 7.5 mg/kg bid in children) for 3 days
Number of subjects: 25
Study 8035693 — intervention group
Group type: EXPERIMENTAL
Intervention: Naming color words
Number of subjects: 0
Study 8035693 — intervention group
Group type: COMPARATOR
Intervention: Blocked lists of color patches
Number of subjects: 0
Study 2655906 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 5 mg three times daily for four weeks
Number of subjects: 32
Study 2655906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 31043158 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 67
Study 31043158 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 67
Study 28291486 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Health Coaching (NHC)
Number of subjects: 435
Study 28291486 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal Supplementation
Number of subjects: 435
Study 28291486 — intervention group
Group type: COMPARATOR
Intervention: Control group (Army MOVE!)
Number of subjects: 435
Study 25358652 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Treatment By Experts (CTBE) with combined treatment model (SFT and DBT)
Number of subjects: 45
Study 25358652 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 45
Study 22748946 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up intervention
Number of subjects: 11
Study 21397400 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 40
Study 21397400 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study 19772451 — intervention group
Group type: EXPERIMENTAL
Intervention: AIR inhaled insulin
Number of subjects: 560
Study 19772451 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (IG)
Number of subjects: 560
Study 19772451 — intervention group
Group type: EXPERIMENTAL
Intervention: AIR inhaled insulin plus intensified insulin glargine (AIR + IG)
Number of subjects: 560
Study 19772451 — intervention group
Group type: EXPERIMENTAL
Intervention: AIR + IG
Number of subjects: 560
Study 19772451 — intervention group
Group type: EXPERIMENTAL
Intervention: AIR alone
Number of subjects: 560
Study 19772451 — intervention group
Group type: COMPARATOR
Intervention: IG alone
Number of subjects: 560
Study 16990198 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g NaCl per day for one week
Number of subjects: 10
Study 16990198 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no sodium chloride) per day for one week
Number of subjects: 10
Study 15570201 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g intravenous cephalosporin (antibiotic prophylaxis)
Number of subjects: 1008
Study 15570201 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 1008
Study 11093066 — intervention group
Group type: EXPERIMENTAL
Intervention: G2457A polymorphism in ABCG1
Number of subjects: 0
Study 11093066 — intervention group
Group type: COMPARATOR
Intervention: Replication study with independent patients and controls
Number of subjects: 0
Study 11093066 — intervention group
Group type: COMPARATOR
Intervention: Suicidal behavior
Number of subjects: 0
Study 9211437 — intervention group
Group type: EXPERIMENTAL
Intervention: d-fenfluramine (30 mg p.o.)
Number of subjects: 40
Study 8350608 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (EX) - 5 sessions of 45 min brisk walking/week at 62 +/- 2% VO2max for 15 weeks
Number of subjects: 36
Study 8350608 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise (NEX) - Control group
Number of subjects: 36
Study 3784305 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25(OH)2-D3 treatment
Number of subjects: 5
Study 3784305 — intervention group
Group type: COMPARATOR
Intervention: Aluminum containing antacids
Number of subjects: 5
Study 3784305 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate
Number of subjects: 5
Study 3784305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 30057064 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation exercises for four weeks
Number of subjects: 84
Study 30057064 — intervention group
Group type: COMPARATOR
Intervention: Standard cares
Number of subjects: 84
Study 27843700 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive observation of a 1-min video depicting the task performed at 3 Hz
Number of subjects: 65
Study 27843700 — intervention group
Group type: COMPARATOR
Intervention: Black screen (control group)
Number of subjects: 65
Study 27843700 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI signal in the left primary motor strip during passive video observation
Number of subjects: 65
Study 24893290 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation (abstainers)
Number of subjects: 1504
Study 24893290 — intervention group
Group type: COMPARATOR
Intervention: Continuing smoking (control group)
Number of subjects: 1504
Study 23513463 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS+AA
Number of subjects: 40
Study 23513463 — intervention group
Group type: COMPARATOR
Intervention: AA
Number of subjects: 40
Study 20219602 — intervention group
Group type: EXPERIMENTAL
Intervention: IAN block with 1.8 mL of Lidocaine 2% with 1:80,000 epinephrine
Number of subjects: 84
Study 20219602 — intervention group
Group type: EXPERIMENTAL
Intervention: IAN block with 3.6 mL of Lidocaine 2% with 1:80,000 epinephrine
Number of subjects: 84
Study 20219602 — intervention group
Group type: EXPERIMENTAL
Intervention: IAN block with 1.8 mL and buccal infiltration with 1.8 mL of Lidocaine 2% with 1:80,000 epinephrine
Number of subjects: 84
Study 18567536 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral subthalamic stimulation (STN stimulation)
Number of subjects: 12
Study 18567536 — intervention group
Group type: COMPARATOR
Intervention: No stimulation (OFF)
Number of subjects: 12
Study 15834325 — intervention group
Group type: EXPERIMENTAL
Intervention: Information Group (nonelastic sacroiliac belt and oral/written information about pelvic girdle pain)
Number of subjects: 118
Study 15834325 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Exercise Group (nonelastic sacroiliac belt, oral/written information, and home exercise program)
Number of subjects: 118
Study 15834325 — intervention group
Group type: EXPERIMENTAL
Intervention: In Clinic Exercise Group (nonelastic sacroiliac belt, oral/written information, and participation in a training program)
Number of subjects: 118
Study 12425844 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operation-education (1 hour of educational video and clinic environment familiarization)
Number of subjects: 150
Study 12425844 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia (1.8 ml of 2% lidocaine injected 15 minutes before treatment)
Number of subjects: 150
Study 12425844 — intervention group
Group type: COMPARATOR
Intervention: Blank control (no intervention)
Number of subjects: 150
Study 10805067 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-based pharmacotherapy training
Number of subjects: 111
Study 10805067 — intervention group
Group type: COMPARATOR
Intervention: Pre-test results
Number of subjects: 111
Study 10805067 — intervention group
Group type: COMPARATOR
Intervention: Basic knowledge about drugs
Number of subjects: 111
Study 8678631 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic CPB (rectal temperature, 27 degrees C to 28 degrees C)
Number of subjects: 30
Study 8678631 — intervention group
Group type: COMPARATOR
Intervention: Normothermic CPB (rectal temperature, more than 35 degrees C)
Number of subjects: 30
Study 1864299 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinolones
Number of subjects: 0
Study 1864299 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose prophylaxis
Number of subjects: 0
Study 7060323 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg verapamil intravenously
Number of subjects: 20
Study 7060323 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg verapamil orally
Number of subjects: 20
Study 7060323 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg verapamil orally
Number of subjects: 20
Study 7060323 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg verapamil orally
Number of subjects: 20
Study 30409780 — intervention group
Group type: EXPERIMENTAL
Intervention: Aldosterone levels in response to angiotensin-II infusion
Number of subjects: 73
Study 30409780 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary flow reserve (CFR)
Number of subjects: 73
Study 30409780 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest myocardial blood flow (MBF)
Number of subjects: 73
Study 30409780 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic function
Number of subjects: 73
Study 30409780 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of rest MBF with diastolic function
Number of subjects: 73
Study 28292758 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted condition
Number of subjects: 10
Study 28292758 — intervention group
Group type: COMPARATOR
Intervention: Fed condition
Number of subjects: 10
Study 25773888 — intervention group
Group type: EXPERIMENTAL
Intervention: PhyS-milk (1.57 g PhyS in 250 ml/day)
Number of subjects: 32
Study 25773888 — intervention group
Group type: EXPERIMENTAL
Intervention: ω3-milk (375 mg ω3 in 250 ml/day)
Number of subjects: 32
Study 23462922 — intervention group
Group type: EXPERIMENTAL
Intervention: Water pipe smoking (average of 3 sessions)
Number of subjects: 13
Study 23462922 — intervention group
Group type: COMPARATOR
Intervention: Cigarette smoking (11 cigarettes per day)
Number of subjects: 13
Study 23462922 — intervention group
Group type: EXPERIMENTAL
Intervention: Water pipe smoking
Number of subjects: 13
Study 21569373 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy following the CAPOX treatment scheme
Number of subjects: 0
Study 21569373 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study 19098490 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 with HAART interruption
Number of subjects: 41
Study 19098490 — intervention group
Group type: COMPARATOR
Intervention: Continuous HAART
Number of subjects: 41
Study 16837878 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg
Number of subjects: 97
Study 16837878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 12174697 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational group (structured educational programme)
Number of subjects: 1230
Study 12174697 — intervention group
Group type: COMPARATOR
Intervention: Normal General Advice group (usual advice from general practitioners)
Number of subjects: 1230
Study 10443725 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg finasteride
Number of subjects: 121
Study 10443725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 8652237 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin-vindesine (EV)
Number of subjects: 295
Study 8652237 — intervention group
Group type: COMPARATOR
Intervention: Mitoxantrone-vindesine (MV)
Number of subjects: 295
Study 2189187 — intervention group
Group type: EXPERIMENTAL
Intervention: Salk killed virus vaccine
Number of subjects: 0
Study 2189187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 375685 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 39
Study 375685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 7044523 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen and aminoglutethimide combination
Number of subjects: 20
Study 7044523 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 20
Study 29239252 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-bundle reconstruction
Number of subjects: 12
Study 29239252 — intervention group
Group type: COMPARATOR
Intervention: Double-bundle reconstruction
Number of subjects: 12
Study 30514362 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS followed by ALND and regional nodal irradiation excluding the dissected axilla
Number of subjects: 1500
Study 30514362 — intervention group
Group type: COMPARATOR
Intervention: TAS followed by regional nodal irradiation including the full axilla
Number of subjects: 1500
Study 26908796 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterolane Maleate-Piperaquine Phosphate (AM-PQP)
Number of subjects: 1072
Study 26908796 — intervention group
Group type: COMPARATOR
Intervention: Artemether-Lumefantrine (A-L)
Number of subjects: 1072
Study 24406207 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug Conservation (DC) treatment strategy
Number of subjects: 1444
Study 24406207 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 1444
Study 24406207 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 1444
Study 24406207 — intervention group
Group type: EXPERIMENTAL
Intervention: Past smoking
Number of subjects: 1444
Study 24406207 — intervention group
Group type: EXPERIMENTAL
Intervention: History of diabetes
Number of subjects: 1444
Study 24406207 — intervention group
Group type: COMPARATOR
Intervention: Control group: Viral Suppression (VS) treatment strategy
Number of subjects: 1444
Study 22835490 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectocele repair surgery
Number of subjects: 160
Study 20379093 — intervention group
Group type: EXPERIMENTAL
Intervention: Lafutidine (20mg)
Number of subjects: 336
Study 20379093 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (40mg)
Number of subjects: 336
Study 20379093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336
Study 20379093 — intervention group
Group type: COMPARATOR
Intervention: Lafutidine vs Placebo
Number of subjects: 336
Study 20379093 — intervention group
Group type: EXPERIMENTAL
Intervention: Judging panels evaluation
Number of subjects: 336
Study 17568759 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate juice
Number of subjects: 53
Study 17568759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 15475601 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg crossing
Number of subjects: 88
Study 15475601 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle tensing
Number of subjects: 88
Study 12060477 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 0
Study 12060477 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance spectroscopy (MRS)
Number of subjects: 0
Study 10402156 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI) after administration of sedatives (alcohol, triazolam, flunitrazepam)
Number of subjects: 4
Study 10402156 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI) after administration of stimulants (cocaine)
Number of subjects: 4
Study 10402156 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI) after administration of opioids (morphine, pentazocine, naloxone)
Number of subjects: 4
Study 7595718 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms twice daily)
Number of subjects: 49
Study 7595718 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 49
Study 2341774 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 147
Study 2341774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 7001898 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug treatment with hydrochlorothiazide, with possible addition of alphamethyldopa or propranolol if needed.
Number of subjects: 785
Study 7001898 — intervention group
Group type: COMPARATOR
Intervention: Control group (no drug treatment).
Number of subjects: 785
Study 7001898 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug treatment group (with diastolic blood pressure >= 100 mm Hg before randomization).
Number of subjects: 785
Study 7001898 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug treatment group.
Number of subjects: 785
Study 31729126 — intervention group
Group type: COMPARATOR
Intervention: Blood pressure lowering medications
Number of subjects: 0
Study 31729126 — intervention group
Group type: COMPARATOR
Intervention: Intensive glucose control
Number of subjects: 0
Study 31729126 — intervention group
Group type: COMPARATOR
Intervention: Standard glucose control
Number of subjects: 0
Study 31430295 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-value offers in the ultimatum game (UG)
Number of subjects: 28
Study 31430295 — intervention group
Group type: COMPARATOR
Intervention: Unfair offers in the ultimatum game (UG)
Number of subjects: 28
Study 31430295 — intervention group
Group type: COMPARATOR
Intervention: Fair offers in the ultimatum game (UG)
Number of subjects: 28
Study 31430295 — intervention group
Group type: COMPARATOR
Intervention: Mid-value offers in the dictator game (DG)
Number of subjects: 28
Study 31430295 — intervention group
Group type: COMPARATOR
Intervention: Unfair offers in the dictator game (DG)
Number of subjects: 28
Study 31430295 — intervention group
Group type: COMPARATOR
Intervention: Fair offers in the dictator game (DG)
Number of subjects: 28
Study 28884732 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense massage of asymmetric chest zones (n=47)
Number of subjects: 137
Study 28884732 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical chest massage (n=46)
Number of subjects: 137
Study 28884732 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (n=44)
Number of subjects: 137
Study 26050626 — intervention group
Group type: EXPERIMENTAL
Intervention: Active video games (AVGs) on the Xbox Kinect, 6 sessions of 50 minutes each
Number of subjects: 36
Study 26050626 — intervention group
Group type: COMPARATOR
Intervention: Control group (no active video games)
Number of subjects: 36
Study 24650825 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based screening and brief intervention via eScreen.se
Number of subjects: 202
Study 24650825 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 202
Study 24650825 — intervention group
Group type: EXPERIMENTAL
Intervention: eScreen.se users
Number of subjects: 202
Study 24650825 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 202
Study 21367545 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 g of ethanol daily (females)
Number of subjects: 44
Study 21367545 — intervention group
Group type: EXPERIMENTAL
Intervention: 32 g of ethanol daily (males)
Number of subjects: 44
Study 21367545 — intervention group
Group type: COMPARATOR
Intervention: Abstinent (no ethanol consumption)
Number of subjects: 44
Study 19581223 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry heat application
Number of subjects: 136
Study 19581223 — intervention group
Group type: COMPARATOR
Intervention: Moist heat application
Number of subjects: 136
Study 17470012 — intervention group
Group type: EXPERIMENTAL
Intervention: graft + PRP
Number of subjects: 25
Study 17470012 — intervention group
Group type: COMPARATOR
Intervention: graft alone (beta‐TCP)
Number of subjects: 25
Study 17470012 — intervention group
Group type: EXPERIMENTAL
Intervention: graft + PRP + membrane
Number of subjects: 25
Study 15023462 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast formulation of starch acetate-diltiazem tablets
Number of subjects: 8
Study 15023462 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate formulation of starch acetate-diltiazem tablets
Number of subjects: 8
Study 15023462 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow formulation of starch acetate-diltiazem tablets
Number of subjects: 8
Study 15023462 — intervention group
Group type: COMPARATOR
Intervention: Commercial reference tablet
Number of subjects: 8
Study 12084445 — intervention group
Group type: COMPARATOR
Intervention: PSP patients
Number of subjects: 36
Study 12084445 — intervention group
Group type: COMPARATOR
Intervention: CBD patients
Number of subjects: 36
Study 9802147 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital organised preventive intervention
Number of subjects: 106
Study 9802147 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 106
Study 9802147 — intervention group
Group type: COMPARATOR
Intervention: No intervention (usual follow-up)
Number of subjects: 106
Study 7638765 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous force of 50 cN (approximately 50 g)
Number of subjects: 144
Study 7638765 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous force of 100 cN (approximately 100 g)
Number of subjects: 144
Study 7638765 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous force of 200 cN (approximately 200 g)
Number of subjects: 144
Study 7638765 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted type of force of 50 cN (approximately 50 g)
Number of subjects: 144
Study 7638765 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention after 8 weeks
Number of subjects: 144
Study 2677862 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ampicillin plus oral erythromycin
Number of subjects: 103